Comparison the effect of valerian and Gabapentin on restless legs syndrome and sleep quality in dialysis patients

Comparative investigating the effect of valerian and Gabapentin on restless legs syndrome and sleep quality in dialysis patients referring to the dialysis ward of Ali Ibn Abi Taleb Hospital of Rafsanjan, 2021

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20150713023190N9

Enrollment

Registered

2021-10-19

Start date

2021-10-23

Completion date

Unknown

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Restless leg syndrome. Restless legs syndrome

Interventions

Intervention 1: Intervention group A: patients will take Sedamin ( capsule: 530 mg made by Isfahan Gol Daroo Company), as a single dose one hour before bedtime for one month. Intervention 2: Intervent

Eligibility

Sex/Gender

All

Age

14 Years to No maximum

Inclusion criteria

Inclusion criteria: Getting a score above 10 from the Restless Legs questionnaire Getting a score above 5 of the Sleep Quality Questionnaire Age over 14 years old Inform consent for participate in the study Satisfaction for taking drugs BMI less than 30 Blood pressure> 110/70

Exclusion criteria

Exclusion criteria: Allergy to valerian Having a physical disability Having mental disorders and being treated with psychiatric drugs Deafness or blindness pregnancy Taking Gabapentin routinely beforehand

Design outcomes

Primary

Measure	Time frame
Mean score of restless leg syndrome. Timepoint: Before and after the each of intervention. Method of measurement: International Restless Legs Syndrome Questionnaire.;Mean score of sleep quality. Timepoint: Before and after the each of intervention. Method of measurement: Pittsburgh Sleep Quality Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactIman Hajizadeh Khanaman

Rafsanjan University of Medical Sciences

iman_hajizadeh@yahoo.com+98 34 3425 5900

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026